Showing results (461-470 of 482) with videos related to
Sort By:
Pageof 49
Cancer Research|February 9, 2024
Single-Cell Analysis Identifies NOTCH3-Mediated Interactions between Stromal Cells That Promote Microenvironment Remodeling and Invasion in Lung AdenocarcinomaHandan Xiang, Yidan Pan, Marc A Sze, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 6, 2026
Predictors of Loco-Regional Recurrence after Pulmonary Non-Anatomical Metastasectomy: A Multicentre Retrospective AnalysisElena Prisciandaro, Luca Bertolaccini, Steffen Fieuws, et al.Nature Cancer|October 7, 2025
A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinomaWilliam Zhao, Thinh T Nguyen, Atharva Bhagwat, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning MeetingRitu R Gill, Anne S Tsao, Hedy L Kindler, et al.Cancer Research|January 4, 2008
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionRamasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 5, 2024
Multicentre retrospective analysis on pulmonary metastasectomy: an European perspectiveElena Prisciandaro, Luca Bertolaccini, Steffen Fieuws, et al.Cancers|May 27, 2026
Correction: Prisciandaro et al. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis. Cancers 2026, 18, 1037Elena Prisciandaro, Luca Bertolaccini, Steffen Fieuws, et al.Cancer Cell|November 20, 2018
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain MutationsKanika Bajaj Pahuja, Thong T Nguyen, Bijay S Jaiswal, et al.The Lancet. Respiratory Medicine|March 27, 2026
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaborationAnne-Marie C Dingemans, Isabelle Opitz, Alessandro Brunelli, et al.Communications Biology|April 15, 2021
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancerGiorgia Maroni, Mahmoud A Bassal, Indira Krishnan, et al.Pageof 49